https://www.investorwire.com/news-articles/biondvax-pharmaceuticals-ltd-nasdaq-bvxv-leverages-top-tier-leadership-and-gmp-facility-to-advance-rapid-development-of-new-therapeutic-and-prophylactic-technologies-for-multiple-diseases-and-diso/
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leverages Top-Tier Leadership and GMP Facility to...
Apr 19, 2023 - BiondVax is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, primarily for the...
leverages topgmp facilitypharmaceuticalsltdnasdaq